OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Publication Date
Release Date
2021
(4)
2023
(3)
2020
(2)
2024
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Accelarated immune ageing is associated with COVID-19 disease severity.
Not available
S-EPMC10782727
|
biostudies-literature
Cite
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.
Not available
S-EPMC10033295
|
biostudies-literature
Cite
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Not available
S-EPMC8377563
|
biostudies-literature
Cite
Whole-genome sequencing of a sporadic primary immunodeficiency cohort.
Not available
S-EPMC7334047
|
biostudies-literature
Cite
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Not available
S-EPMC7255743
|
biostudies-literature
Cite
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185
|
biostudies-literature
Cite
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Not available
S-EPMC9634600
|
biostudies-literature
Cite
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Not available
S-EPMC8497028
|
biostudies-literature
Cite
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Not available
S-EPMC7894131
|
biostudies-literature
Cite
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Not available
S-EPMC7723445
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets